Pharmacological investigations on efficacy of Phlorizin a sodium-glucose co-transporter (SGLT) inhibitor in mouse model of intracerebroventricular streptozotocin induced dementia of AD type.

Abstract

OBJECTIVES:

The study has been commenced to discover the potential of Phlorizin (dual SGLT inhibitor) in streptozotocin induced dementia of Alzheimer's disease (AD) type.

MATERIAL AND METHODS:

Injection of Streptozotocin (STZ) was given via i.c.v. route (3 mg/kg) to induce dementia of Alzheimer's type. In these animals learning and memory was evaluated using Morris water maze (MWM) test. Glutathione (GSH) and thiobarbituric acid reactive species (TBARS) level was quantified to evaluate the oxidative stress; cholinergic activity of brain was estimated in term of acetylcholinesterase (AChE) activity; and the levels of myeloperoxidase (MPO) were measured as inflammation marker.

RESULTS:

The mice model had decreased performance in MWM, representing impairment of cognitive functions. Biochemical evaluation showed rise in TBARS level, MPO and AChE activity, and fall in GSH level. The histopathological study revealed severe infiltration of neutrophils. In the study, Phlorizin/Donepezil (serving as positive control) treatment mitigate streptozotocin induced cognitive decline, histopathological changes and biochemical alterations.

CONCLUSIONS:

The results suggest that Phlorizin decreased cognitive function via its anticholinesterase, antioxidative, antiinflammatory effects and probably through SGLT inhibitory action. It can be conferred that SGLTs can be an encouraging target for the treatment of dementia of AD.

• Authors: Reena Rani, Amit Kumar, Amteshwar Singh Jaggi, Nirmal Singh
• Journal: Journal of basic and clinical physiology and pharmacology (J Basic Clin Physiol Pharmacol) Vol. 32 Issue 6 Pg. 1057-1064 (Feb 08 2021) ISSN: 2191-0286 [Electronic] Germany
• PMID: 33548170 (Publication Type: Journal Article)
• Copyright: © 2021 Walter de Gruyter GmbH, Berlin/Boston.

Chemical References

• Symporters
• Streptozocin
• Sodium
• Phlorhizin
• Acetylcholinesterase
• Glucose

Topics

• Acetylcholinesterase (metabolism)
• Alzheimer Disease (chemically induced, drug therapy)
• Animals
• Brain (metabolism)
• Disease Models, Animal
• Glucose (therapeutic use)
• Maze Learning
• Mice
• Oxidative Stress
• Phlorhizin (adverse effects)
• Sodium (adverse effects)
• Streptozocin (pharmacology)
• Symporters (adverse effects)